::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

RISK OF PNEUMONIA IN CHRONIC LUNG DISEASE AMONG LOCAL POPULATION OF PAKISTAN

AUTHORS:

Dr. Sobia Abbas, Dr Balaj Hassan, Dr Maha Arshad

ABSTRACT:

Introduction: Despite the fact that free vaccination is available in Pakistan, pneumonia is killing around 92,000 children annually under-five years of age, health experts said Tuesday during a press briefing to mark upcoming World Pneumonia Day on November 12. Objective: The main objective of the study is to analyze the risk of pneumonia in chronic lung disease among local population of Pakistan. Methodology of the study: This study was conducted at District Hospital Vehari during January 2019 to June 2019. This study was done with the permission of ethical committee. For this purpose we select 50 patients of pneumonia for further analysis. The patients of both gender were selected for this study. Result: Significant differences were observed between patients who received extra-fine versus fine-particle COPD in the demographics and baseline characteristics, as shown in Table 1. The COPD treatments prescribed to patients before and at step-up are shown in S1 Table in the supporting information. Conclusion: In conclusion, the COPD exacerbation rate was higher among the patients who had a history of pneumonia or a high rate of COPD exacerbation in the preceding period of 1 year.